Dermatophagoides Farinae Interactions

FDA Black Box Warning

WARNING: ANAPHYLAXIS Do not inject intravenously. (2.2) Allergenic extracts may potentially elicit a severe life-threatening systemic reaction, rarely resulting in death. (5.1) This allergenic product is intended for use only by physicians who are experienced in the administration of allergenic extracts and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist. (5.1) The initial dose must be based on skin test. (2.1) Observe patients in the office for at least 30 minutes following treatment. Emergency measures and personnel trained in their use must be available immediately in the event of life threatening reaction. (5.1) Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to survive a systemic reaction, including significant cardiovascular and/or pulmonary diseases. Patients who are receiving beta blockers may be unresponsive to the usual doses of epinephrine used to treat systemic reactions, including anaphylaxis. (5.2) WARNING: ANAPHYLAXIS See full prescribing information for complete boxed warning. Do not inject intravenously (2.2) Allergenic extracts may cause severe life-threatening systemic reactions, including the rare occurrence of anaphylaxis or death (5.1) Intended for use only by experts experienced in administering allergic extracts and trained to provide emergency treatment (5.1) Initial dose must be based on skin test (2.1) Observe patients in the office for at least 30 minutes following treatment. Emergency measures and personnel trained in their use must be available immediately in the event of life threatening reaction (5.1) Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to survive a systemic reaction (5)